Bayer Audioupdate
Follicular lymphoma: Label expension for Zevalin in Europe
1:27 min.
April 28, 2008 - The European Commission has extended the marketing authorization for Bayer’s cancer drug Zevalin, a product used to treat follicular lymphoma, the most common form of lymphoma.
download mp3
Add to iTunes
Bayer Audio update(requires that iTunes be installed)
Copyright © Bayer AG
